Press release
H5N1 Infection (Avian Influenza) – Industry Pipeline Review, Key Players and Emerging Growth Report, H1, 2016
H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2016 Size and Share Published in 2016-05-25 Available for US$ 2000 at Researchmoz.usDescription
To access full report, please visit : http://www.researchmoz.us/h5n1-infection-avian-influenza-pipeline-review-h1-2016-report.html
Global Markets Directs, H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2016, provides an overview of the H5N1 Infection (Avian Influenza) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for H5N1 Infection (Avian Influenza), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for H5N1 Infection (Avian Influenza) and features dormant and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.
Get a Free Sample Copy of the Report: http://www.researchmoz.us/enquiry.php?type=S&repid=739351
Scope
- The report provides a snapshot of the global therapeutic landscape of H5N1 Infection (Avian Influenza)
- The report reviews pipeline therapeutics for H5N1 Infection (Avian Influenza) by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved H5N1 Infection (Avian Influenza) therapeutics and enlists all their major and minor projects
- The report assesses H5N1 Infection (Avian Influenza) therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for H5N1 Infection (Avian Influenza)
Reasons to buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for H5N1 Infection (Avian Influenza)
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding H5N1 Infection (Avian Influenza) pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Table of Content
Table of Contents 2
Introduction 6
H5N1 ITable of Contents 2
Introduction 6
H5N1 Infection (Avian Influenza) Overview 7
Therapeutics Development 8
H5N1 Infection (Avian Influenza) - Therapeutics under Development by Companies 10
H5N1 Infection (Avian Influenza) - Therapeutics under Investigation by Universities/Institutes 13
H5N1 Infection (Avian Influenza) - Pipeline Products Glance 14
H5N1 Infection (Avian Influenza) - Products under Development by Companies 17
H5N1 Infection (Avian Influenza) - Products under Investigation by Universities/Institutes 21
H5N1 Infection (Avian Influenza) - Companies Involved in Therapeutics Development 22
H5N1 Infection (Avian Influenza) - Therapeutics Assessment 60
Drug Profiles 70
H5N1 Infection (Avian Influenza) - Recent Pipeline Updates 158
H5N1 Infection (Avian Influenza) - Dormant Projects 186
H5N1 Infection (Avian Influenza) - Discontinued Products 191
H5N1 Infection (Avian Influenza) - Product Development Milestones 192
Appendix 199nfection (Avian Influenza) Overview 7
Therapeutics Development 8
H5N1 Infection (Avian Influenza) - Therapeutics under Development by Companies 10
H5N1 Infection (Avian Influenza) - Therapeutics under Investigation by Universities/Institutes 13
H5N1 Infection (Avian Influenza) - Pipeline Products Glance 14
H5N1 Infection (Avian Influenza) - Products under Development by Companies 17
H5N1 Infection (Avian Influenza) - Products under Investigation by Universities/Institutes 21
H5N1 Infection (Avian Influenza) - Companies Involved in Therapeutics Development 22
H5N1 Infection (Avian Influenza) - Therapeutics Assessment 60
Drug Profiles 70
H5N1 Infection (Avian Influenza) - Recent Pipeline Updates 158
H5N1 Infection (Avian Influenza) - Dormant Projects 186
H5N1 Infection (Avian Influenza) - Discontinued Products 191
H5N1 Infection (Avian Influenza) - Product Development Milestones 192
Appendix 199
About ResearchMoz
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives.
Contact Us:
ResearchMoz
Mr. Nachiket Ghumare, +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
sales@researchmoz.us
http://www.researchmoz.us/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release H5N1 Infection (Avian Influenza) – Industry Pipeline Review, Key Players and Emerging Growth Report, H1, 2016 here
News-ID: 354615 • Views: …
More Releases from Researchmoz
Robotic Process Automation (RPA) Market 2021-2026: Market Analysis, Drivers, Res …
Robotic Process Automation (RPA) Market Report offers a detailed analysis of the industry size, regional landscape and therefore the revenue forecast concerning this vertical. The report further highlights the primary challenges and latest growth strategies embraced by key players that constitute the dynamic competitive spectrum of this business domain.
Crucial information and forecast statistics covered within the Robotic Process Automation (RPA) Market report will arm both existing and emerging market players…
Know in depth about Voice and Speech Analytics Market – Growth, Opportunities …
Voice and Speech Analytics Market Report offers a detailed analysis of the industry size, regional landscape and therefore the revenue forecast concerning this vertical. The report further highlights the primary challenges and latest growth strategies embraced by key players that constitute the dynamic competitive spectrum of this business domain.
Crucial information and forecast statistics covered within the Voice and Speech Analytics Market report will arm both existing and emerging market players…
Digital Remittance Market Dynamics, Comprehensive Analysis, Growth Prospects and …
This report on the global Digital Remittance Market assures a treasure of information on a plethora of growth opportunities. All the growth factors revolving around the Digital Remittance market across the assessment period of 2020-2026 have been systematically included in the report. The indepth assessment includes including enabling technologies, key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles…
Microbiome Therapeutics Market is Booming Worldwide – Gaining Revolution in Ey …
This report on the global Microbiome Therapeutics Market assures a treasure of information on a plethora of growth opportunities. All the growth factors revolving around the Microbiome Therapeutics market across the assessment period of 2020-2026 have been systematically included in the report. The indepth assessment includes including enabling technologies, key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles…
More Releases for H5N1
Global H5N1 Influenza Disease Treatment Market Size, Share and Forecast 2028 | S …
The persuasive H5N1 Influenza Disease Treatment Market business report endows with current and upcoming technical and financial details of the industry to 2028 and hence proves to be a valuable source of information. The data and information included in this market report helps industry take sound decisions and plan about the advertising and sales promotion strategy more successfully. An expert team along with project managers serve the clients on…
Influenza A Virus H5N1 Subtype Infections-Pipeline Review H2 2018
H5N1 is a type of influenza virus that causes a highly infectious, severe respiratory disease in birds called avian influenza. This virus can spread to humans. Symptoms include fever and cough, acute respiratory distress, shortness of breath/difficulty breathing, abdominal pain and diarrhea. Predisposing factors include work with poultry, touch an infected bird and eating raw or undercooked poultry meat. Treatment includes antiviral medications.
Report Highlights
Publisher's Pharmaceutical and Healthcare latest pipeline guide…
Influenza A Virus, H5N1 Subtype Infections - Pipeline Review Report, H2 2017 wit …
Market Research HUB's Pharmaceutical and Healthcare latest pipeline guide Influenza A Virus, H5N1 Subtype Infections - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Influenza A Virus, H5N1 Subtype Infections (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research…
Healthcare disease pipeline guide Influenza A Virus, H5N1 Subtype Infections - M …
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H5N1 Subtype Infections Pipeline Review, H1 2017, provides an overview of the Influenza A Virus, H5N1 Subtype Infections (Infectious Disease) pipeline landscape.
Request For Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1049096
H5N1 is a type of influenza virus that causes a highly infectious, severe respiratory disease in birds called avian influenza. This virus can spread to humans. Symptoms include fever and cough,…
Global H5N1 Infection (Avian Influenza) Clinical Trials Review by Country and Sp …
"The Report H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H1, 2016 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
MarketResearchReports.biz has announced the addition of a new report, titled “H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H1, 2016.” The research study offers a 360-degree overview of clinical trials on H5N1 (avian influenza) conducted worldwide.
H5N1 is considered a highly pathogenic…
Rapid Early Detection of H5N1 Avian Flu/SARS/Bird Flu by AgroMicron
Millions of chickens culled, loss of life and fear have all be a result H5N1 Avian Flu/SARS/Bird and now thanks to AgroMicron maybe there is some light at the end of this tunnel.
Identifying carriers of H5N1 Avian Flu (AKA SARS or Bird Flu) before they board planes, enter countries and infect others is a top priority for many countries and individuals, we are all fearful of a major epidemic. …
